Kyverna Therapeutics Inc (KYTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KYTX | AZN | AMGN | GILD | VRTX |
| Company | Kyverna Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 8.56 | 89.40 | 317.30 | 122.86 | 444.81 |
| High | 9.75 | 89.89 | 319.46 | 123.63 | 456.00 |
| Low | 8.45 | 89.28 | 315.19 | 121.83 | 444.81 |
| Latest | 9.21 | 89.33 | 315.66 | 121.90 | 450.60 |
| Change | +0.85 | -0.96 | -1.72 | -1.31 | +4.67 |
| % Change | +10.17% | -1.06% | -0.54% | -1.06% | +1.05% |
| Volume | 766,753 | 2,700,321 | 807,010 | 1,662,938 | 595,408 |
| 20-Day Average Volume | 500,297 | 5,548,759 | 2,784,787 | 6,791,270 | 1,336,306 |
| Previous Close | 8.36 | 90.29 | 317.38 | 123.21 | 445.93 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.65 | 90.59 | 333.97 | 124.34 | 437.57 |
| 20-Day Raw Stochastic | 86.76% | 24.06% | 11.87% | 41.76% | 70.74% |
| 20-Day Relative Strength | 62.99 | 54.87 | 47.00 | 51.49 | 58.81 |
| Weighted Alpha | +80.96 | +37.46 | +16.86 | +31.47 | +1.20 |
| Today's Opinion | 100% Buy | 88% Buy | 72% Buy | 72% Buy | 40% Buy |
| Previous Opinion | 100% Buy | 88% Buy | 72% Buy | 72% Buy | 40% Buy |
| Last Month's Opinion | 96% Buy | 100% Buy | 56% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.29% since 12/05/25 | -0.58% since 12/05/25 | -4.08% since 12/05/25 | +1.40% since 12/05/25 | -1.07% since 12/05/25 |
| Low | 7.62 on 12/08/25 | 89.34 on 12/12/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 433.81 on 12/10/25 |
| High | 9.75 on 12/12/25 | 91.66 on 12/10/25 | 329.67 on 12/08/25 | 123.74 on 12/11/25 | 457.17 on 12/08/25 |
| 1-Month | |||||
| %Chg | +26.94% since 11/12/25 | +2.26% since 11/12/25 | -5.91% since 11/12/25 | -0.39% since 11/12/25 | +3.78% since 11/12/25 |
| Low | 6.39 on 11/14/25 | 87.62 on 11/13/25 | 312.39 on 12/11/25 | 118.78 on 12/10/25 | 418.53 on 11/19/25 |
| High | 9.75 on 12/12/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 3-Month | |||||
| %Chg | +137.37% since 09/12/25 | +12.69% since 09/12/25 | +14.48% since 09/12/25 | +7.31% since 09/12/25 | +14.21% since 09/12/25 |
| Low | 3.78 on 09/15/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 9.75 on 12/12/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 463.85 on 12/03/25 |
| 6-Month | |||||
| %Chg | +168.93% since 06/12/25 | +19.55% since 06/12/25 | +6.43% since 06/12/25 | +9.70% since 06/12/25 | -2.06% since 06/12/25 |
| Low | 2.52 on 07/08/25 | 68.61 on 07/21/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 362.50 on 08/11/25 |
| High | 9.75 on 12/12/25 | 94.01 on 11/26/25 | 346.38 on 12/03/25 | 128.70 on 11/20/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 366,135 | 280,027,776 | 170,903,104 | 152,864,192 | 113,140,912 |
| Shares Outstanding, K | 43,796 | 3,101,426 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -127,480,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -36,790,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 3.66 | 0.32 | 0.45 | 0.32 | 0.32 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.85 on 11/12/25 | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/26/26 | 02/05/26 | 02/03/26 | 02/10/26 | 02/09/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.02 | 14.42 | 14.82 | 29.04 |